Mesenchymal stem cells alleviate Japanese encephalitis virus-induced neuroinflammation and mortality

Abstract

BackgroundJapanese encephalitis virus (JEV) is the leading cause of viral encephalitis in Asia. Japanese encephalitis (JE) caused by JEV is characterized by extensive inflammatory cytokine secretion, microglia activation, blood-brain barrier (BBB) breakdown, and neuronal death, all of which contribute to the vicious cycle of inflammatory damage. There are currently no effective treatments for JE. Mesenchymal stem cells (MSCs) have been demonstrated to have a therapeutic effect on many central nervous system (CNS) diseases by regulating inflammation and other mechanisms.MethodsIn vivo, 8- to 10-week-old mice were infected intraperitoneally with JEV and syngeneic bone marrow MSCs were administered through the caudal vein at 1 and 3 days post-infection. The mortality, body weight, and behavior were monitored daily. Brains from each group were harvested at the indicated times for hematoxylin and eosin staining, immunohistochemical observation, flow cytometric analysis, TUNEL staining, Western blot, quantitative real-time polymerase chain reaction, and BBB permeability assays. In vitro, co-culture and mixed culture experiments of MSCs with either microglia or neurons were performed, and then the activation state of microglia and survival rate of neurons were tested 48 h post-infection.ResultsMSC treatment reduced JEV-induced mortality and improved the recovery from JE in our mouse model. The inflammatory response, microglia activation, neuronal damage, BBB destruction, and viral load (VL) were significantly decreased in the MSC-treated group. In co-culture experiments, MSCs reprogrammed M1-to-M2 switching in microglia and improved neuron survival. Additionally, the VL was decreased in Neuro2a cells in the presence of MSCs accompanied by increased expression of interferon-α/β.ConclusionMSC treatment alleviated JEV-induced inflammation and mortality in mice.Electronic supplementary materialThe online version of this article (doi:10.1186/s13287-017-0486-5) contains supplementary material, which is available to authorized users.

miR-301a Regulates Inflammatory Response to Japanese Encephalitis Virus Infection via Suppression of NKRF Activity

“…The activation of microglia is considered to be the cardinal hallmark of neuroinflammation, and is characterized by its morphological change to M1 phenotype, as well as secretion of a series of proinflammatory mediators. M1 activation of microglia followed by neuroinflammation is a common feature of Japanese encephalitis (36). Following JEV invasion, glial cells elicit immune response against pathogens; however, viral replication within microglia results in bystander neuronal death by secretion of inflammatory mediators (4).…”

Rg1 improves LPS-induced Parkinsonian symptoms in mice via inhibition of NF-κB signaling and modulation of M1/M2 polarization

“…Intracerebral inflammation can cause death in PD patients [ 31 , 32 ]. The mortality of LPS-induced PD mice was not reported in previous studies, but we demonstrated for the first time that 10, 20, and 40 mg/kg Rg1 treatment decreased mouse mortality by 12.5%, 25.7%, and 25.7%, respectively, compared to that in the LPS-only group.…”

Potential Therapeutic Effect of Allogenic Mesenchymal Stem Cells on Chronic Cerebral Murine Toxoplasmosis

“…In this study, mice (n=5) from each group were euthanized by cervical dislocation, on the 7 th , 14 th days after starting treatment administration. Such times were proven to be effective for successful testing of the therapeutic MSCs effect on the infected mice [22].…”